Lumos Pharma Inc (LUMO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard J. Hawkins
Employees:
55
4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
515-296-5555

Lumos Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for severe, rare, and genetic diseases.

Data derived from most recent annual or quarterly report
Market Cap 75.384 Million Shares Outstanding8.357 Million Avg 30-day Volume 9.199 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 36.72 / 7.23 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from LUMO instead.

View recent insider trading info

Funds Holding LUMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LUMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

58.6 Thousand total shares from 8 transactions

Open Market Sells (S)

2.2 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LALANDE KEVIN M.

  • Director
731,522 2021-09-08 8

MCKEW JOHN C. CHIEF SCIENTIFIC OFFICER

  • Officer
31,012 2021-09-08 4

KARPF DAVID B CHIEF MEDICAL OFFICER

  • Officer
7,500 2021-09-01 1

MCCRACKEN JOSEPH S

  • Director
8,551 2021-08-11 2

SCHUCHART AARON CHIEF BUSINESS OFFICER

  • Officer
3,037 2021-08-11 3

LAWLEY LORI D CHIEF FINANCIAL OFFICER

  • Officer
30,437 2021-08-01 3

ZOTH LOTA S.

  • Director
5,097 2021-05-20 1

RAFFIN THOMAS A.

  • Director
11,166 2021-05-20 1

JOHNSON CHAD ALLEN

  • Director
3,986 2021-05-20 1

VAN ES-JOHANSSON AN

  • Director
4,010 2021-05-20 2

HAWKINS RICHARD J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
745,382 2021-04-01 2

LANGREN CARL W. CHIEF FINANCIAL OFFICER

  • Officer
17,015 2021-04-01 2

POWERS BRADLEY J GENERAL COUNSEL

  • Officer
5,109 2021-04-01 2

KENNEDY EUGENE P. CHIEF MEDICAL OFFICER

  • Officer
11,423 2021-02-01 1

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2021-01-06 1

CUNNINGHAM EMMETT

  • Director
709 2020-04-03 0

LINK CHARLES J. JR. CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
0 2019-08-02 0

SHERMAN MATTHEW L

  • Director
0 2019-07-31 0

VAHANIAN NICHOLAS N. PRESIDENT

  • Officer
0 2019-07-31 0

TALARICO ERNEST III

  • Director
0 2019-07-31 0

HENNEMAN JOHN B III CHIEF ADMINISTRATIVE OFFICER

  • Officer
55,052 2018-10-01 0

PUCCI PAOLO

  • Director
0 2018-05-23 0

WILEY BRIAN CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-03-09 0

STINE SEED FARM, INC.

  • 10% Owner
7,857,732 2017-10-06 0

SALURI JOSEPH

  • Director
0 2017-05-12 0

EDICK PAUL R

  • Director
0 2017-05-12 0

RAMSEY WILLIAM J. QUALITY ASSURANCE OFFICER

  • Officer
No longer subject to file 2015-06-01 0

LINK GORDON H JR CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2014-10-24 0

LYNN KENNETH

  • NO LONGER REPORTING OFFICER
No longer subject to file 2012-06-27 0

LUNDQUIST DAVID J.

  • Director
87,630 2011-11-16 0

ALEXANDER SARAH

  • Director
5,833 2011-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCKEW JOHN C. - Officer CHIEF SCIENTIFIC OFFICER

2021-09-10 16:58:00 -0400 2021-09-08 S 2,214 $11.30 d 31,012 direct yes -3.8462 -4.0385 -13.2692 7.3077 4 -13.6538 17

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-10 16:57:41 -0400 2021-09-08 P 10,000 $11.21 a 730,446 indirect -3.8462 -4.0385 -13.2692 7.3077 4 -13.6538 17

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-07 17:56:48 -0400 2021-09-07 P 10,000 $11.11 a 720,446 indirect -0.4509 -5.5005 -16.1407 0.9017 3 -19.0261 20

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-07 17:56:48 -0400 2021-09-03 P 8,100 $11.35 a 710,446 indirect -0.4509 -5.5005 -16.1407 0.9017 3 -19.0261 20

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-07 17:56:48 -0400 2021-09-02 P 6,300 $11.23 a 702,346 indirect -0.4509 -5.5005 -16.1407 0.9017 3 -19.0261 20

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-01 18:46:32 -0400 2021-09-01 P 4,589 $10.87 a 696,046 indirect -0.088 -1.4965 -18.5739 0.0 1 -20.9507 23

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-01 18:46:32 -0400 2021-08-31 P 6,000 $10.70 a 691,457 indirect -0.088 -1.4965 -18.5739 0.0 1 -20.9507 23

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-09-01 18:46:32 -0400 2021-08-30 P 8,625 $10.52 a 685,457 indirect -0.088 -1.4965 -18.5739 0.0 1 -20.9507 23

LALANDE KEVIN M. - Director by sante health ventures ii, lp

2021-08-27 19:16:48 -0400 2021-08-27 P 4,981 $10.50 a 677,832 indirect 2.262 4.9953 -10.4618 7.0688 4 -15.3629 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LUMOS PHARMA INC LUMO 2021-10-26 22:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 21:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 21:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 20:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 20:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 19:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 19:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 18:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 18:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 17:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 17:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 16:45:04 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 16:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 15:45:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 15:15:03 UTC -4.6888 4.7588 100000
LUMOS PHARMA INC LUMO 2021-10-26 14:45:03 UTC -4.5111 4.5811 100000
LUMOS PHARMA INC LUMO 2021-10-26 14:15:05 UTC -4.5111 4.5811 100000
LUMOS PHARMA INC LUMO 2021-10-26 13:45:03 UTC -4.5111 4.5811 100000
LUMOS PHARMA INC LUMO 2021-10-26 13:15:03 UTC -4.5111 4.5811 100000
LUMOS PHARMA INC LUMO 2021-10-26 12:45:03 UTC -4.5111 4.5811 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund LUMO -222.0 shares, $-2206.68 2021-06-30 N-PORT

Elevate your investments